儿童MRI卒中评估方案中常规增强颈部MRA的成本与效用
本研究回顾性分析2010年9月至2017年6月在一家三级儿童医院接受儿童卒中MRI方案(含DWI、GRE/SWI、Willis环MRA和3D增强颈部MRA)的681例18岁以下患者,仅1例(0.15%)在脑部序列均报告正常而增强颈部MRA报告异常,估计额外增加Medicare费用超过20万美元、患者自付费用8万美元;作者认为常规增强颈部MRA在儿童卒中MRI方案中效用极低,颈部MRA应合理限制用于脑部标准序列初筛发现异常、或表现不典型/复发病理的患者。
要点
- 在681例儿童卒中MRI方案中,仅1例(0.15%)脑部DWI、SWI/GRE和Willis环MRA均正常而增强颈部MRA异常。
- 常规增强颈部MRA的附加检出率极低,估计增加Medicare费用超过20万美元、患者自付8万美元。
- 作者认为颈部MRA应合理限制用于脑部标准序列发现异常或表现不典型/复发病理的患者。
核心结论
- 在本大系列中,将常规增强颈部MRA加入儿童卒中MR成像方案的效用极低。
- 作者认为颈部MRA应合理限制用于脑部标准序列初筛发现异常、或表现不典型/复发病理的患者。
研究设计与样本
- 回顾性检索机构PACS数据库,纳入2010年9月至2017年6月接受包含DWI、GRE或SWI、Willis环MRA和3D增强颈部MRA的卒中方案MRI、年龄小于18岁的患者,共筛查681例。
- 参考标准为DWI、SWI/GRE或Willis环MRA的单独报告结果与增强颈部MRA报告结果的比较。
关键影像表现/征象
- 仅1例(0.15%)DWI、SWI/GRE和Willis环MRA均分别报告正常,而增强颈部MRA报告异常。
诊断标准与关键数值
- 以DWI、SWI/GRE和Willis环MRA均报告正常为条件,增强颈部MRA异常检出率为0.15%(1/681)。
临床应用与阅片要点
- 作者认为颈部MRA应合理限制用于脑部标准序列初筛发现异常、或表现不典型/复发病理的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Cervical arterial dissection is one of the frequent causes of pediatric arterial ischemic stroke. Out of concern for missing cervical arterial dissection in patients in whom pediatric stroke is suspected, our tertiary children's hospital added contrast-enhanced 3D neck MR angiography to every pediatric stoke work-up. This research investigated whether the routine use of contrast-enhanced neck MRA in our MR imaging stroke protocol ever detected a cervical arterial abnormality when the DWI, SWI/gradient recalled-echo, or circle of Willis MRA findings from the brain MR imaging were reported as normal.
MATERIALS AND METHODS: The institutional PACS data base was searched for stroke protocol MRIs that included DWI, gradient recalled-echo or SWI, circle of Willis MRA, and 3D contrast-enhanced neck MRA in patients younger than 18 years of age with examinations performed between September 2010 and June 2017.
RESULTS: In only a single case (0.15%) were the DWI, SWI/gradient recalled-echo, or circle of Willis MRA findings all separately reported as normal and the contrast-enhanced neck MRA findings reported as abnormal. To reach these findings, we screened 681 patients, which would have resulted in an estimated >$200,000 in Medicare charges and $80,000 in of out-of-pocket cost to patients.
CONCLUSIONS: In our large series, the addition of a routine contrast-enhanced neck MRA to our pediatric stroke MR imaging protocol was of extremely low yield. We believe the use of neck MRA should reasonably be limited to cases in which abnormalities are initially detected on standard brain sequences or to patients with atypical presentation or recurrent pathology.
引用
- Baltensperger A, Mirsky D, Maloney J, et al. Cost and Utility of Routine Contrast-Enhanced Neck MRA in a Pediatric MRI Stroke Evaluation Protocol. AJNR Am J Neuroradiol. 2019. PMID: 31727745. doi:10.3174/ajnr.A6315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。